Position in ROIV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$618,144,423
-$8,414,949 QoQ
Shares Held
17,466,641
-22.8% QoQ
Ownership
2.42%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#9
of 489 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,271,661 across 562 Biotechnology names. ROIV ranks #2 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
This page
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in ROIV
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $618,144,423 | 17,466,641 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $626,559,372 | 22,619,472 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $399,080,184 | 18,390,792 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $41,531,184 | 2,744,956 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $57,398,874 | 5,093,068 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $68,583,776 | 6,797,203 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $62,578,024 | 5,289,774 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,893,845 | 510,732 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,225,268 | 494,349 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,666,271 | 537,597 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,626,572 | 233,889 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,690,440 | 230,346 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $3,820,822 | 379,050 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $55,866 | 7,570 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,286,485 | 161,012 | Shares | Sole | 2023-02-08 | |
| No filing history on record for this holder in this stock. | ||||||